Measurable residual disease by flow cytometry in acute myeloid leukemia is prognostic, independent of genomic profiling.
- DOI
- 10.1016/j.leukres.2022.106971
- Published
- 2022 Dec
- Container
- Leukemia research
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.leukres.2022.106971,
title = {Measurable residual disease by flow cytometry in acute myeloid leukemia is prognostic, independent of genomic profiling.},
author = {Ganzel C and Sun Z and Baslan T and Zhang Y and Gönen M and Abdel-Wahab OI and Racevskis J and Garrett-Bakelman F and Lowe SW and Fernandez HF and Ketterling R and Luger SM and Litzow M and Lazarus HM and Rowe JM and Tallman MS and Levine RL and Paietta E},
year = {2022},
journal = {Leukemia research},
doi = {10.1016/j.leukres.2022.106971},
url = {https://doi.org/10.1016/j.leukres.2022.106971}
}RIS
TY - JOUR TI - Measurable residual disease by flow cytometry in acute myeloid leukemia is prognostic, independent of genomic profiling. AU - Ganzel C AU - Sun Z AU - Baslan T AU - Zhang Y AU - Gönen M AU - Abdel-Wahab OI AU - Racevskis J AU - Garrett-Bakelman F AU - Lowe SW AU - Fernandez HF AU - Ketterling R AU - Luger SM AU - Litzow M AU - Lazarus HM AU - Rowe JM AU - Tallman MS AU - Levine RL AU - Paietta E PY - 2022 JO - Leukemia research DO - 10.1016/j.leukres.2022.106971 UR - https://doi.org/10.1016/j.leukres.2022.106971 ER -
APA
C, G., Z, S., T, B., Y, Z., M, G., OI, A., J, R., F, G., SW, L., HF, F., R, K., SM, L., M, L., HM, L., JM, R., MS, T., RL, L., & E, P. (2022). Measurable residual disease by flow cytometry in acute myeloid leukemia is prognostic, independent of genomic profiling.. Leukemia research. https://doi.org/10.1016/j.leukres.2022.106971
Source records
- pubmed · retrieved 2026-09-27T01:05:06.135Z